Dr. Patrick Mote Elangwe, MD

Dr. Elangwe practices at OSF St. Joseph Medical Center in Bloomington, Illinois, part of OSF HealthCare System.

Dr. Elangwe's NPI, 1114226958, was assigned on March 18, 2011. Dr. Elangwe holds Indiana license 01074624A.

Dr. Elangwe's primary practice is OSF St. Joseph Medical Center, at 2200 E Washington, Bloomington, IL 61701 in Mc Lean County. The practice phone is (309) 662-3311.

Dr. Elangwe's primary practice is OSF St. Joseph Medical Center in Bloomington, Illinois, part of OSF HealthCare System. Dr. Elangwe is also affiliated with OSF Saint Francis Medical Center. The medical group on file is OSF Multi-Specialty Group. Dmand AI also links Dr. Elangwe to 4 more hospitals, 10 medical groups, 1 breast imaging center, 1 group practice or clinic and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Elangwe practices, 9 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Elangwe's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dmand AI has Dr. Elangwe's licenses on file in 3 states: Indiana, Illinois and Ohio.

CMS data shows 926 Medicare services from Dr. Elangwe across 7 procedure codes in 2024, for 348 Medicare patients. Medicare paid $72,044 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 348 Medicare patients who saw Dr. Elangwe in 2024. The largest group is 75 to 84, with 115 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 33% are also on Medicaid. Their average risk score is 2.48, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Elangwe's median patient age at 78, with 56% women.

In 2024, Dr. Elangwe wrote 369 Medicare Part D claims for 150 patients. 90% of them were for generic drugs. CMS names the drug for 135 of them, across 9 drugs with 11 or more claims each, at $616 in total drug cost. In 2023, CMS named 140 claims across 9 drugs.

Dr. Elangwe accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 22 general payments to Dr. Elangwe from 10 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Sunovion Pharmaceuticals Inc. paid the most, $61.